Related Experiment Video
Updated: May 7, 2026

Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
Published on: October 21, 2017
Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia
Yi-Bing Ouyang1, Lijun Xu, Yu Lu
1Department of Anesthesia, Stanford University School of Medicine, Stanford, California.
Abstract:
Following transient forebrain ischemia, astrocytes play a key role in determining whether or not neurons in the hippocampal CA1 sector go on to die in a delayed fashion. MicroRNAs (miRNAs) are a novel class of RNAs that control gene expression at the post-transcriptional level and the miR-29 family is highly expressed in astrocytes. In this study we assessed levels of miR-29 in hippocampus following forebrain ischemia and found that after transient forebrain ischemia and short periods of reperfusion, miR-29a significantly increased in the resistant dentate gyrus, but decreased in the vulnerable CA1 region of the hippocampus. We demonstrate that miR-29a targets BH3-only proapoptotic BCL2 family member PUMA by luciferase reporter assay and by Western blot. Comparing primary neuron and astrocyte cultures, and postnatal brain, we verified the strongly astrocytic expression of miR-29a. We further found that miR-29a mimic protects and miR-29a inhibitor aggravates cell injury and mitochondrial function after ischemia-like stresses in vitro. Lastly, by overexpressing and reducing miR-29a we demonstrate the protective effect of miR-29a on CA1 delayed neuronal death after forebrain ischemia. Our data suggest that by targeting a pro-apoptotic BCL2 family member, increasing levels of miR-29a might emerge as a strategy for protection against ischemia-reperfusion injury.
Insights
MicroRNAs (miRNAs) like miR-29a play a crucial role in astrocyte-mediated neuronal death after brain ischemia. Increasing miR-29a levels may protect against ischemia-reperfusion injury by targeting pro-apoptotic factors.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Astrocytes influence neuronal survival after transient forebrain ischemia.
- MicroRNAs (miRNAs) regulate gene expression post-transcriptionally.
- The miR-29 family is notably expressed in astrocytes.
Purpose of the Study:
- To investigate the role of miR-29 in hippocampal CA1 neuronal death following forebrain ischemia.
- To determine if miR-29a targets the pro-apoptotic protein PUMA.
- To evaluate the therapeutic potential of modulating miR-29a levels in ischemia-reperfusion injury.
Main Methods:
- Assessed miR-29 levels in hippocampus post-ischemia using quantitative methods.
- Utilized luciferase reporter assays and Western blots to identify miR-29a targets.
- Employed primary neuron and astrocyte cultures, and in vivo models to study miR-29a function.
- Manipulated miR-29a levels using mimics and inhibitors in vitro and in vivo.
Main Results:
- miR-29a levels decreased in the vulnerable CA1 region but increased in the resistant dentate gyrus after ischemia.
- miR-29a was confirmed to target and downregulate the pro-apoptotic protein PUMA.
- Astrocytic miR-29a expression was verified.
- miR-29a mimic conferred protection against cell injury and neuronal death, while an inhibitor exacerbated it.
- Overexpression of miR-29a reduced delayed neuronal death in the CA1 sector.
Conclusions:
- miR-29a levels are differentially regulated in hippocampal subregions following forebrain ischemia.
- miR-29a exerts a neuroprotective effect by targeting the pro-apoptotic protein PUMA.
- Modulating astrocytic miR-29a represents a potential therapeutic strategy for mitigating ischemia-reperfusion injury.
